Nephrology

Sharing key updates in the field in the form of reviews and research articles, our latest release features insights into COVID-19-associated nephropathy, diabetic kidney disease, and perspectives on the use of sodium-glucose co-transporter inhibitors in kidney disease.

In an interview conducted by EMJ, leading experts from the field of nephrology and renal medicine discussed the high mortality rates in patients on long-term haemodialysis (HD), despite the recent developments in treatment.

CHRONIC kidney disease (CKD) affects approximately 700 million individuals worldwide. Many patients with CKD require haemodialysis, and more than two-thirds of these patients have CKD-associated pruritus (CKD-aP). CKD-aP can be bothersome for many patients and drastically affect quality of life, from causing sleep issues to mental health problems. Almost 40% of dialysis patients are at least ‘moderately’ bothered and 19% of patients are at least very much bothered by pruritus.

PRURITUS is a common challenging symptom seen in chronic kidney disease (CKD). Approximately 40% of patients with end-stage renal…

This issue of EMJ Nephrology includes the latest peer-reviewed research alongside a review of the ERA–EDTA Congress 2021.

Chronic kidney disease associated pruritis (CKD-aP) can be a highly vexatious problem that disrupts sleep, impacts quality of life (QoL)…

In this supplement to EMJ Nephrology, two leading nephrologists, Patrice Ambühl and Jordi Bover, discussed the burden and management…

“ANTI-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: From Diagnosis to Outcomes,” reviews posters presented at…